Hot Stocks: Brokerage view on Dalmia Bharat, Axis Bank, Kotak Bank and Aurobindo Pharma

April 25, 2024

Morgan Stanley reiterated its overweight rating on Dalmia Bharat, while Macquarie advised an outperform rating for Axis Bank. Jefferies sustained a hold rating on Kotak Mahindra Bank, and Investec endorsed a buy rating for Aurobindo Pharma.

More To Explore

Death Crossovers: These 5 stocks signal bearishness on March 17

In the Nifty500 pack, five stocks are witnessing Death Crossovers, according to stockedge.com’s technical scan data. The death cross is a technical indicator of bearishness.

March 17, 2025

KEC International shares in focus after securing new orders worth Rs 1,267 crore

KEC International has secured new orders worth Rs 1,267 crore, boosting the company’s total year-to-date order intake to Rs 23,300 crore. The firm has won

March 17, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003